课题基金 / 基金详情

Kava for the Treatment of Generalized Anxiety Disorder: A 16-Week Double-Blind RCT

Kava for the Treatment of Generalized Anxiety Disorder: A 16-Week Double-Blind RCT
卡瓦治疗广泛性焦虑症:为期 16 周的双盲随机对照试验
批准号:
nhmrc : 1063383
负责人:
Dr Chad Bousman
金额:
$45.38万
依托单位:
依托单位国家:
澳大利亚
项目类别:
Project Grants
财政年份:
2014
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2014-01-01 至 2017-12-31

项目摘要

项目成果

Dr Chad Bousman的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Herbal medicines play a prominent role in traditional medicine to treat affective disorders (mood and anxiety disorders), however scientific studies are needed to truly assess their effectiveness. This clinical trial is examining the anxiolytic efficacy of Kava in treating chronic anxiety. As current response to antidepressant drugs can be inadequate, Kava may offer an additional affordable, safe, and effective option to reduce anxiety.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PHARMACOGENETICS OF ANTIDEPRESSANT RESPONSE AND REMISSION: TOWARD GENOTYPE-GUIDED PRESCRIBING IN MAJOR DEPRESSIVE DISORDER
  • 批准号:
    nhmrc : 1127700
  • 项目类别:
    Career Development Fellowships
  • 资助金额:
    $29.04万
  • 财政年份:
    2017
  • 负责人:
    Dr Chad Bousman
  • 依托单位:
The Efficacy of Adjunctive S-Adenosyl Methionine (SAMe) versus a Combination Nutraceutical in Clinical Depression: A Double-Blind, Randomised, Placebo-Controlled Trial
  • 批准号:
    nhmrc : 1048222
  • 项目类别:
    Project Grants
  • 资助金额:
    $53.36万
  • 财政年份:
    2013
  • 负责人:
    Dr Chad Bousman
  • 依托单位:
海外基金